Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Lung Cancer

Free Subscription 24.06.2024 1 Am J Clin Oncol 3 Am J Pathol 3 Ann Surg Oncol 2 Arch Bronconeumol 1 BMC Cancer 1 Cancer Epidemiol Biomarkers Prev 5 Cancer Lett 2 Cancer Sci 1 Chest 4 Clin Lung Cancer 1 Clin Nucl Med 1 Int J Cancer 1 J Cancer Res Clin Oncol 1 J Clin Oncol 3 J Thorac Cardiovasc Surg 1 J Thorac Oncol 5 Lung Cancer 2 Nat Med 1 PLoS Genet 2 PLoS One 1 Science 4 Thorax

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Clin Oncol

1. LIU C, Gao F, Yang J, Liu C, et al
   Wilms' Tumor 1-Associating Protein Promotes Nonsmall-Cell Lung Cancer Through the Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5.
   Am J Clin Oncol. 2024 Jun 20. doi: 10.1097/COC.0000000000001116.
   PubMed         Abstract available
   
   

   
   Am J Pathol

2. LAN H, Chen P, Wang C, Chen C, et al
   CUNet3+: A Multi-scale Connected UNet for the Segmentation of Lung Cancer Cells in Pathology Sections Stained using Rapid On-Site Cytopathological Evaluation.
   Am J Pathol. 2024 Jun 17:S0002-9440(24)00210.
   PubMed         Abstract available
   
   
3. YIN Y, Cui Q, Zhao J, Wu Q, et al
   Integrated Bioinformatics and Machine Learning Analysis Identify ACADL as a Potent Biomarker of Reactive Mesothelial Cells.
   Am J Pathol. 2024;194:1294-1305.
   PubMed         Abstract available
   
   
4. GINDRA RH, Zheng Y, Green EJ, Reid ME, et al
   Graph Perceiver Network for Lung Tumor and Bronchial Premalignant Lesion Stratification from Histopathology.
   Am J Pathol. 2024;194:1285-1293.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

5. LI X, Fan F, Chen H
   ASO Author Reflections: Long-Term Follow-Up Results of Stage IA Invasive Non-Small Cell Lung Cancer Patients.
   Ann Surg Oncol. 2024 Jun 20. doi: 10.1245/s10434-024-15615.
   PubMed        
   
   
6. KANZAKI R, Fukuda H, Kobayashi M, Horiguchi J, et al
   ASO Visual Abstract: Pathological Pleural Invasion is a Risk Factor for Late Recurrence in Long-Term Survivors of Non-small Cell Lung Cancer After Complete Resection.
   Ann Surg Oncol. 2024 Jun 20. doi: 10.1245/s10434-024-15628.
   PubMed        
   
   
7. LI X, Fan F, Yang Z, Huang Q, et al
   Ten-Year Follow-Up of Lung Cancer Patients with Resected Stage IA Invasive Non-Small Cell Lung Cancer.
   Ann Surg Oncol. 2024 Jun 18. doi: 10.1245/s10434-024-15572.
   PubMed         Abstract available
   
   

   
   Arch Bronconeumol

8. BAEZA S, Gil D, Sanchez C, Torres G, et al
   Radiomics and Clinical Data for the Diagnosis of Incidental Pulmonary Nodules and Lung Cancer Screening: Radiolung Integrative Predictive Model.
   Arch Bronconeumol. 2024 May 31:S0300-2896(24)00192.
   PubMed         Abstract available
   
   
9. GUERRA-TORT C, Lopez-Vizcaino E, Santiago-Perez MI, Rey-Brandariz J, et al
   Time Dependence Between Tobacco Consumption and Lung Cancer Mortality in Spain.
   Arch Bronconeumol. 2024 May 31:S0300-2896(24)00193.
   PubMed         Abstract available
   
   

   
   BMC Cancer

10. XIAO X, Sun Z, Liang S, Li W, et al
    Liquid-based cytology specimens for next-generation sequencing in lung adenocarcinoma: challenges and evaluation of targeted therapy.
    BMC Cancer. 2024;24:749.
    PubMed         Abstract available
    
    

    
    Cancer Epidemiol Biomarkers Prev

11. SMELTZER MP, Akinbobola OA, Ray MA, Fehnel C, et al
    Prevalence of Epidermal Growth Factor Receptor and Programmed Death-Ligand 1 testing in a population-based lung cancer surgical resection cohort from 2018-2022.
    Cancer Epidemiol Biomarkers Prev. 2024.
    PubMed         Abstract available
    
    

    
    Cancer Lett

12. LIU M, Gu L, Zhang Y, Li Y, et al
    LKB1 inhibits telomerase activity resulting in cellular senescence through histone lactylation in lung adenocarcinoma.
    Cancer Lett. 2024;595:217025.
    PubMed         Abstract available
    
    
13. FLETCHER K, Cortellini A, Ganta T, Kankaria R, et al
    Safety and efficacy outcomes of early cessation of anti-PD1 therapy in patients 80 years or older: A retrospective cohort study.
    Cancer Lett. 2024;596:217001.
    PubMed         Abstract available
    
    
14. KIM YJ, Lee M, Kim EH, Lee S, et al
    Real-world incidences and risk factors of immune-related adverse events in patients treated with immune checkpoint inhibitors: A nationwide retrospective cohort study.
    Cancer Lett. 2024;596:216998.
    PubMed         Abstract available
    
    
15. CHOW Z, Johnson J, Chauhan A, Jeong JC, et al
    Inhibition of ribonucleotide reductase subunit M2 enhances the radiosensitivity of metastatic pancreatic neuroendocrine tumor.
    Cancer Lett. 2024;596:216993.
    PubMed         Abstract available
    
    
16. LU Y, Sun Y, Zhang J, Kong M, et al
    The deubiquitinase USP2a promotes tumor immunosuppression by stabilizing immune checkpoint B7-H4 in lung adenocarcinoma harboring EGFR-activating mutants.
    Cancer Lett. 2024;596:217020.
    PubMed         Abstract available
    
    

    
    Cancer Sci

17. WANG J, Wang S, Yang H, Wang R, et al
    Methyltransferase like-14 suppresses growth and metastasis of non-small-cell lung cancer by decreasing LINC02747.
    Cancer Sci. 2024 Jun 18. doi: 10.1111/cas.16254.
    PubMed         Abstract available
    
    
18. ZHANG C, Yang L, Zhao W, Zhu H, et al
    A heterogeneous tumor immune microenvironment of uncommon epidermal growth factor receptor mutant non-small cell lung cancer.
    Cancer Sci. 2024 Jun 18. doi: 10.1111/cas.16253.
    PubMed         Abstract available
    
    

    
    Chest

19. DETTERBECK FC, Woodard GA, Bader AS, Dacic S, et al
    The Proposed 9th Edition TNM Classification of Lung Cancer.
    Chest. 2024 Jun 15:S0012-3692(24)00706-2. doi: 10.1016/j.chest.2024.
    PubMed         Abstract available
    
    

    
    Clin Lung Cancer

20. LU S, Zhou Q, Liu X, Du Y, et al
    Updated Efficacy and Safety of Lorlatinib in a Phase 2 Study in Chinese Patients With Previously Treated Advanced ALK-Positive Non-small Cell Lung Cancer.
    Clin Lung Cancer. 2024 Apr 30:S1525-7304(24)00079.
    PubMed         Abstract available
    
    
21. AWIDI M, Mier-Hicks A, Perimbeti S, Attwood K, et al
    Patients' Preferences for Adjuvant Osimertinib in Non-Small-Cell Lung Cancer After Complete Surgical Resection: What Makes It Worth It to Patients?
    Clin Lung Cancer. 2024 May 29:S1525-7304(24)00082.
    PubMed         Abstract available
    
    
22. THOSANI DS, Meredith LT, West R, Till BM, et al
    Association Between Utilization of Services and Perioperative Outcomes for Lung Cancer Resection.
    Clin Lung Cancer. 2024 May 20:S1525-7304(24)00097.
    PubMed         Abstract available
    
    
23. CHRISTENSEN NL, Gouliaev A, McPhail S, Lyratzopoulos G, et al
    Routes to Diagnosis in Danish Lung Cancer Patients: Emergency Presentation, Age and Smoking History-A Population-Based Cohort Study.
    Clin Lung Cancer. 2024 May 25:S1525-7304(24)00108.
    PubMed         Abstract available
    
    

    
    Clin Nucl Med

24. HUA Q, Wang W, Qu G, Pei W, et al
    Flare Phenomenon After 177Lu-DOTA-IBA Therapy in Bone Metastases of Lung Cancer.
    Clin Nucl Med. 2024 Jun 18. doi: 10.1097/RLU.0000000000005303.
    PubMed         Abstract available
    
    

    
    Int J Cancer

25. MELOSKY B, Vincent MD, McGuire AL, Brade AM, et al
    Modern era systemic therapies: Expanding concepts of cure in early and locally advanced non-small cell lung cancer.
    Int J Cancer. 2024 Jun 20. doi: 10.1002/ijc.35031.
    PubMed         Abstract available
    
    

    
    J Cancer Res Clin Oncol

26. FENG Y, Qian R, Cui D, Luan J, et al
    Mutant TP53 promotes invasion of lung cancer cells by regulating desmoglein 3.
    J Cancer Res Clin Oncol. 2024;150:312.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

27. 
    Erratum: Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Mutated Non-Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04).
    J Clin Oncol. 2024 Jun 17:JCO2401092. doi: 10.1200/JCO.24.01092.
    PubMed        
    
    

    
    J Thorac Cardiovasc Surg

28. BOTT MJ
    Commentary: Cracking the Code: Deciphering Predictors of Treatment Response in Non-Small Cell Lung Cancer.
    J Thorac Cardiovasc Surg. 2024 Jun 13:S0022-5223(24)00527.
    PubMed        
    
    
29. MACBETH F, Williams N, Ahmad I, Treasure T, et al
    Lung surveillance following colorectal cancer pulmonary metastasectomy: Utilization of clinicopathologic risk factors to guide strategy.
    J Thorac Cardiovasc Surg. 2024;168:e10-e11.
    PubMed        
    
    
30. ANTONOFF MB, Kui N, Sun R, Deboever N, et al
    Factors associated with receipt of pulmonary metastasectomy in patients with lung-limited metastatic colorectal cancer: Disparities in care and impact on overall survival.
    J Thorac Cardiovasc Surg. 2024;168:263-271.
    PubMed         Abstract available
    
    

    
    J Thorac Oncol

31. SPICER JD, Cascone T, Wynes MW, Ahn MJ, et al
    Neoadjuvant and Adjuvant Treatment for Early-Stage Resectable Non-small Cell Lung Cancer (NSCLC): Consensus Recommendations from the International Association for the Study of Lung Cancer (IASLC).
    J Thorac Oncol. 2024 Jun 18:S1556-0864(24)00627.
    PubMed         Abstract available
    
    

    
    Lung Cancer

32. ARRIETA O
    In response to "On the Hispanic paradox in lung cancer".
    Lung Cancer. 2024;193:107853.
    PubMed        
    
    
33. MAHMOOD K, Wang H, Ji Z, Giovacchini CX, et al
    Differences in microenvironment of lung cancer and pleural effusions by single-cell RNA sequencing.
    Lung Cancer. 2024;193:107847.
    PubMed         Abstract available
    
    
34. TAKEDA M, Shimokawa M, Nakamura A, Nosaki K, et al
    Corrigendum to "A phase II study (WJOG12819L) to assess the efficacy of osimertinib in patients with EGFR mutation-positive NSCLC in whom systemic disease (T790M-negative) progressed after treatment with first- or second-generation EGFR TKI and platin
    Lung Cancer. 2024 Jun 17:107852. doi: 10.1016/j.lungcan.2024.107852.
    PubMed        
    
    
35. CUPPENS K, Du Pont B, Knegjens J, Maes B, et al
    Immune checkpoint inhibition in early-stage non-small cell lung cancer.
    Lung Cancer. 2024;193:107855.
    PubMed         Abstract available
    
    
36. ASANO Y, Yamamoto N, Demura S, Hayashi K, et al
    Combination therapy with immune checkpoint inhibitors and denosumab improves clinical outcomes in non-small cell lung cancer with bone metastases.
    Lung Cancer. 2024;193:107858.
    PubMed         Abstract available
    
    

    
    Nat Med

37. PETERS S, Gadgeel SM, Mok T, Nadal E, et al
    Entrectinib in ROS1-positive advanced non-small cell lung cancer: the phase 2/3 BFAST trial.
    Nat Med. 2024 Jun 19. doi: 10.1038/s41591-024-03008.
    PubMed         Abstract available
    
    
38. WIDMAN AJ, Shah M, Frydendahl A, Halmos D, et al
    Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment.
    Nat Med. 2024;30:1655-1666.
    PubMed         Abstract available
    
    

    
    PLoS Genet

39. KONG Y, Li C, Liu J, Wu S, et al
    Single-cell analysis identifies PLK1 as a driver of immunosuppressive tumor microenvironment in LUAD.
    PLoS Genet. 2024;20:e1011309.
    PubMed         Abstract available
    
    

    
    PLoS One

40. ALSHEHRI MA, Asiri SA, Helmi N, Baeissa HM, et al
    Unrevealing the multitargeted potency of 3-1-BCMIYPPA against lung cancer structural maintenance and suppression proteins through pharmacokinetics, QM-DFT, and multiscale MD simulation studies.
    PLoS One. 2024;19:e0303784.
    PubMed         Abstract available
    
    
41. YU H, Wang Y, Yue X, Zhang H, et al
    Influence of the atmospheric environment on spatial variation of lung cancer incidence in China.
    PLoS One. 2024;19:e0305345.
    PubMed         Abstract available
    
    

    
    Science

42. MATHEW D, Marmarelis ME, Foley C, Bauml JM, et al
    Combined JAK inhibition and PD-1 immunotherapy for non-small cell lung cancer patients.
    Science. 2024;384:eadf1329.
    PubMed         Abstract available
    
    

    
    Thorax

43. SIMS D, Kerry A, Billingham K
    Actinomycosis mimicking metastatic lung malignancy.
    Thorax. 2024;79:694-695.
    PubMed        
    
    
44. SANTONI-RUGIU E
    To progress or not to progress: new insights into the evolution of pleuropulmonary blastomas come from studying lung cysts in adolescents and adults with DICER1-related tumour predisposition.
    Thorax. 2024;79:593-594.
    PubMed        
    
    
45. NELSON AT, Vasta LM, Watson D, Kim J, et al
    Prevalence of lung cysts in adolescents and adults with a germline DICER1 pathogenic/likely pathogenic variant: a report from the National Institutes of Health and International Pleuropulmonary Blastoma/DICER1 Registry.
    Thorax. 2024;79:644-651.
    PubMed         Abstract available
    
    
46. GU C, Yuan H, Yang C, Xie F, et al
    Transbronchial cryoablation in peripheral lung parenchyma with a novel thin cryoprobe and initial clinical testing.
    Thorax. 2024;79:633-643.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.